Medicaid spent an estimated $21.0 billion on outpatient prescribed drugs in 2000. Expenditures for drugs grew more than twice as fast as total Medicaid spending from 1997 to 2000, and officials from nearly every state cited pharmacy costs as one of the top two or three Medicaid cost drivers in 2001. Faced with double-digit Medicaid spending growth and declining revenue growth, states and the federal government are under pressure to find effective methods to control spending. This report presents data on Medicaid drug spending trends, summarizes states’ options in designing their drug benefits, and reviews several ways that states are using their flexibility to curb the rate of growth of their Medicaid drug budgets. (Published by the Kaiser Commission on Medicaid and the Uninsured; 2002 February.)
The nonpartisan Urban Institute publishes studies, reports, and books on timely topics worthy of public consideration. The views expressed are those of the authors and should not be attributed to the Urban Institute, its trustees, or its funders.
Usage, posting and reprint of materials on the UI web site:
Most publications may be downloaded free of charge from the web site in PDF format. This information may be used and copies made for research, academic, policy or other non-commercial purposes. Proper attribution is required.
Copyright of the written materials contained within the Urban Institute website is owned or controlled by the Urban Institute. Posting UI research papers on other websites is permitted subject to prior approval from the Urban Institute—contact paffairs@urban.org.
If you are unable to access or print the PDF document please contact us or call the Publications Office at (202) 261-5687.
Browse by Topic:
